Systematic review / meta-analysis / 2016
Vitamin B supplementation did not alter overall cancer incidence or total mortality.
A meta-analysis of 18 randomized controlled trials with 74,498 participants evaluated vitamin B supplementation. Supplements did not affect cancer incidence (RR 1.04, 95% CI: 0.98 to 1.10), cancer mortality (RR 1.05, 95% CI: 0.90 to 1.22), or all-cause mortality (RR 1.00, 95% CI: 0.94 to 1.06). When evaluating individual malignancies, supplementation lowered the occurrence of skin melanoma (RR 0.47, 95% CI: 0.23 to 0.94).
- Study type
- Cumulative meta-analysis of randomized controlled trials
- Who was studied
- 74,498 individuals across 18 randomized controlled trials
- What was measured
- Cancer incidence, cancer-related death, and total mortality
THE PAPER
Effect of vitamin B supplementation on cancer incidence, death due to cancer, and total mortality: A PRISMA-compliant cumulative meta-analysis of randomized controlled trials.
Zhang SL, Chen TS, Ma CY, Meng YB, Zhang YF, Chen YW, Zhou YH. Medicine (Baltimore), 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.